Biopharma Shakti: India’s Bold Move for Health Excellence

Finance Minister Nirmala Sitharaman just tossed out the ‘Biopharma Shakti’ plan—₹10,000 crore to turn India into a biopharma titan! This isn’t just a sprinkle of hope; it’s a full-on kitchen blitz against diseases like diabetes and cancer. New NIPERs, a thousand clinical trial sites, and a regulatory shake-up so sharp it’ll cut through the nonsense! Get it right, India, or it’s a disaster on your plate!




